Showing results (1021-1030 of 1,211) with videos related to
Sort By:
Pageof 122
European Journal of Heart Failure|November 12, 2021
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HFJawad H Butt, Kieran F Docherty, Pardeep S Jhund, et al.JACC. Heart Failure|December 31, 2021
Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection FractionKieran F Docherty, Modele O Ogunniyi, Inder S Anand, et al.BMC Cardiovascular Disorders|February 14, 2022
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging studyAshutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam, et al.Lancet (London, England)|February 5, 2022
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trialSanjiv J Shah, Barry A Borlaug, Eugene S Chung, et al.European Journal of Heart Failure|May 16, 2023
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trialAna Barat, Chien-Wei Chen, Natasha Patel-Murray, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.Circulation. Heart Failure|November 8, 2025
Effect of Aficamten in Women Compared with Men with Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCMXiaowen Wang, Maria A Pabon, Tracy T Makuvire, et al.European Heart Journal|August 15, 2021
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionAlice M Jackson, Pardeep S Jhund, Inder S Anand, et al.JAMA Cardiology|March 5, 2025
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model: A Secondary Analysis of FINEARTS-HFKirsty McDowell, Kieran F Docherty, Ross T Campbell, et al.JAMA Cardiology|May 29, 2024
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart FailureJohn W Ostrominski, Stephen J Greene, Ravi B Patel, et al.Pageof 122